Dr. Ken Masui Fujimura, MD

Dr. Fujimura practices at West Coast Neurology, Inc in Pasadena, California.

Dr. Fujimura's NPI, 1629426630, was assigned on May 31, 2016. Dr. Fujimura graduated from New York Medical College in 2016. Dr. Fujimura holds Colorado license DR.0068239.

Dr. Fujimura's primary practice is West Coast Neurology, Inc, at 630 S Raymond Ave, Pasadena, CA 91105 in Los Angeles County. The practice phone is (626) 598-3770.

Dr. Fujimura's primary practice is West Coast Neurology, Inc in Pasadena, California. Dr. Fujimura is also affiliated with WakeMed Raleigh Campus. The medical group on file is West Coast Neurology. Dmand AI also links Dr. Fujimura to 7 more hospitals, 12 medical groups and 5 group practices and clinics, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Fujimura practices, 13 sites in all. Vendor and product names are available with a free account.

Neurology is Dr. Fujimura's primary specialty in the NPI Registry, under taxonomy code 2084N0400X. Dr. Fujimura is board certified in clinical neurophysiology by the American Board of Psychiatry and Neurology. Dmand AI has Dr. Fujimura's licenses on file in 15 states: Colorado, South Dakota, Florida, Georgia, Iowa, Maine, North Dakota, New Mexico, Tennessee, Arkansas, California, Illinois, Kentucky, Louisiana and Missouri.

Dmand AI lists acute mini-stroke (TIA), alzheimer's disease, carpal tunnel syndrome, head injury, hereditary polyneuropathy, lower back pain, migraine and chronic headache and neck pain and spine problems among the conditions Dr. Fujimura treats.

CMS data shows 2,624 Medicare services from Dr. Fujimura across 19 procedure codes in 2024, for 755 Medicare patients. Medicare paid $159,285 for them.

CMS counts 755 Medicare patients who saw Dr. Fujimura in 2024. The largest group is 65 to 74, with 374 patients. 75% of them have arthritis, and 75% have high blood pressure. 17% are also on Medicaid. Their average risk score is 1.18, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Fujimura's median patient age at 62, with 57% women.

In 2024, Dr. Fujimura wrote 396 Medicare Part D claims for 76 patients. 94% of them were for generic drugs. CMS names the drug for 302 of them, across 11 drugs with 11 or more claims each, at $6,035 in total drug cost. In 2023, CMS named 306 claims across 13 drugs.

Dr. Fujimura accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Fujimura as offering telehealth.

Dmand AI links 11 papers to Dr. Fujimura, published from 2012 to 2024. 2018 was the busiest year, with 3. The most frequent topics are Pancreatic Neoplasms, Peptide Initiation Factors and Cell Line, Tumor. Dr. Fujimura has published most often in Cancer Res. Dr. Fujimura's most frequent co-authors are Michael Bouvet, MD, Paul J. Anderson, MD, PhD and Grace Y. Lin, MD, PhD.

CMS Open Payments shows 414 general payments to Dr. Fujimura from 61 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. UCB, Inc. paid the most, $994.

Dr. Fujimura graduated from New York Medical College in 2016.

Dr. Fujimura is in network with 21 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. HMO plans come from the most carriers, 12. Check the plan with the practice before a visit.